MRI-Guided Focused Ultrasound in Parkinson’s Disease: A Review

Table 1

Characteristics of Parkinson’s disease patients that underwent MRgFUS treatment.

Authors & year	Target	Patients,	Age, y; (range)	Sex, m	Tremor dominant	Levodopa treatment	Disease duration, y; (range)
Magara et al. 2014	Pallidothalamic tract	13	64.5; (37–82)	8	9	11	9.7; (3–27)
Schlesinger et al. 2015	Thalamotomy	7	59; (46–74)	6	7	3	5.4; (2.5–10)
Na et al. 2015	Pallidotomy	1	56	0	0	1	12
Zaaroor et al. 2017	Thalamotomy		62.8; (46–75)	11	12	5	7.1; (2–16)

the 12 patients in Zaaroor et al., 7 are the same patients as in Schlesinger et al.